Atrium Therapeutics Inc (RNA)

Equity Ratio

76.49%

Quarterly · Period ending:

RNA logo

RNA Equity Ratio

Latest reported76.49%
RNA Quarterly Equity Ratio (76.69% → 76.49%)
High-resolution chart · PNG

RNA equity ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Atrium Therapeutics Inc Equity Ratio — Quarterly
Period endingEquity Ratio
76.4944%
80.0739%
74.4691%
76.6916%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.